Forms of Rifaximin and uses thereof

Details for Australian Patent Application No. 2009219342 (hide)

Owner Salix Pharmaceuticals, Ltd.

Inventors Stults, Jeffrey S.; Vlahova, Petinka; Houston, Travis L.; Schultheiss, Nathan; Yang, Donglai; Roe, Melanie; Gushurst, Karen S.

Agent Pizzeys

Pub. Number AU-A-2009219342

PCT Pub. Number WO2009/108730

Priority 61/031,329 25.02.08 US

Filing date 25 February 2009

Wipo publication date 3 September 2009

International Classifications

C07D 498/00 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/108730 Priority application(s): WO2009/108730

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009219346-Stackable communications system

2009219339-High performance toilet capable of operation at reduced flush volumes